Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2044|59|8|803-810

ISSN： 0003-2409

Source： ANAESTHESIA, Vol.59, Iss.8, 2004-08, pp. : 803-810

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the Oral Direct Thrombin Inhibitor Ximelagatran on P-Selectin Expression and Thrombin Generation in Atrial Fibrillation

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 2, 2003-11 ,pp. : 68-74

Karger

Access to resources Recommend Favorite

Ximelagatran in Orthopaedic Surgery

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-04 ,pp. : 10-17

Karger

Access to resources Recommend Favorite

Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 7, 2015-10 ,pp. : 1115-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design of Randomized, double‐blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE‐SPECT ESUS)

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 8, 2015-12 ,pp. : 1309-1312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 217-226

Karger

Access to resources Recommend Favorite